AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN

Trial ID or NCT#

NCT01976299

Status

not recruiting iconNOT RECRUITING

Purpose

The Osprey Medical AVERT System is indicated to reduce contrast media (CM) exposure to the kidneys during percutaneous coronary procedures thereby reducing the risk of contrast induced nephropathy (CIN).

Official Title

AVERT™ Clinical Trial

Eligibility Criteria

Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Show Less

View on ClinicalTrials.gov